Hepion Pharmaceuticals, Inc. (HEPA)

Hepion Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	13.11	14.79	51.19	91.35	40.73	13.92
Cash & Cash Equivalents	13.11	14.79	51.19	91.35	40.73	13.92
Cash Growth	-69.52%	-71.12%	-43.96%	124.30%	192.52%	391.56%
Other Current Assets	2.32	2.7	5.31	6.1	1.91	0.47
Total Current Assets	15.43	17.49	56.5	97.45	42.63	14.39
Property, Plant & Equipment	0.18	0.24	0.13	0.46	0.66	0.86
Goodwill and Intangibles	0	0	0	1.87	1.87	1.87
Other Long-Term Assets	0.38	0.36	3.62	3.77	3.48	3.5
Total Long-Term Assets	0.56	0.61	3.75	6.1	6.01	6.22
Total Assets	15.99	18.09	60.24	103.55	48.65	20.61
Accounts Payable	1.5	2.35	2.67	2.45	3.72	0.49
Current Debt	0.13	0.12	0.05	0.27	0.28	0.27
Other Current Liabilities	0.94	2.83	5.17	5.49	0.66	0.85
Total Current Liabilities	2.57	5.29	7.89	8.21	4.66	1.61
Long-Term Debt	0.04	0.09	0	0.05	0.47	0.54
Other Long-Term Liabilities	5.85	5.43	2.5	2.3	2.99	2.84
Total Long-Term Liabilities	5.89	5.52	2.5	2.35	3.46	3.39
Total Liabilities	8.47	10.81	10.39	10.56	8.12	4.99
Total Debt	0.18	0.21	0.05	0.32	0.75	0.81
Debt Growth	-	289.86%	-83.09%	-57.86%	-6.85%	-43.93%
Retained Earnings	-227.48	-224.63	-175.7	-133.5	-104.11	-83.75
Comprehensive Income	0.01	-0.08	-0.09	0	0	0
Shareholders' Equity	7.52	7.28	49.86	93	40.52	15.62
Net Cash / Debt	12.93	14.58	51.14	91.03	39.97	13.12
Net Cash / Debt Growth	-69.93%	-71.49%	-43.83%	127.72%	204.79%	841.92%
Net Cash Per Share	2.55	3.67	13.42	25.90	82.61	128.38
Working Capital	12.86	12.2	48.61	89.25	37.97	12.78
Book Value Per Share	1.48	1.83	13.08	26.46	83.74	152.86

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).